Your search history is turned on.
Date: May 2, 2024 19:37:21 EST Jurisdictions: Alberta, British Columbia, Ontario
FOR IMMEDIATE RELEASE News Release May 2, 2024 PREVECEUTICAL ANNOUNCES MANAGEMENT CEASE TRADE ORDER Vancouver, British Columbia, May 2, 2024 - PreveCeutical Medical Inc. (the Company or PreveCeutical) (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) announces that the Company has missed the filing deadline of April 29, 2024 to file the Com...
Date: December 4, 2023 Jurisdictions: Alberta, British Columbia, Ontario
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM VANCOUVER, BC, Dec. 4, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased t...
Date: November 21, 2023 Jurisdictions: Alberta, British Columbia, Ontario
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Stephen Van Deventer, Chief Financial Officer of PreveCeutical Medical Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of PreveCeutical Medical Inc. (the Issuer) for the interim period ended September...
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Stephen Van Deventer, Chief Executive Officer of PreveCeutical Medical Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of PreveCeutical Medical Inc. (the Issuer) for the interim period ended Sep...
PREVECEUTICAL MEDICAL INC. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 Page 1 The following managements discussion and analysis (MD&A) of the financial condition and results of operations of PreveCeutical Medical Inc. (PreveCeutical or the Company) and its subsidiary, PreveCeutical (Australia) ...
PreveCeutical Medical Inc. Condensed Interim Consolidated Financial Statements For the three and nine months ended September 30, 2023 and 2022 Unaudited - Expressed in Canadian Dollars NOTICE TO READER Under National Instrument 51-102, Part 4, subsection 4.3(3)(a)...
Date: September 18, 2023 Jurisdictions: Alberta, British Columbia, Ontario
PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application VANCOUVER, BC, Sept. 18, 2023 /CNW/ - PreveCe...
Date: September 12, 2023 Jurisdictions: Alberta, British Columbia, Ontario
PreveCeutical Showcases Dynamic Evolution in AI Strategy PreveCeutical Showcases Dynamic Evolution in AI Strategy VANCOUVER, BC, Sept. 12, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an important chapter in the journey of PreveCeutical Medical Inc., a pioneering figure in the realm of medic...
Date: September 2, 2023 Jurisdictions: Alberta, British Columbia, Ontario
PreveCeutical Engages New to the Street for Production & Broadcasting Services PreveCeutical Engages New to the Street for Production & Broadcasting Services VANCOUVER, BC, Aug. 31, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announces that it has entered into a Service Agreement dated effective September 1, 2023 (the "Agreement") ...
Date: August 24, 2023 Jurisdictions: Alberta, British Columbia, Ontario
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Stephen Van Deventer, Chief Executive Officer of PreveCeutical Medical Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of PreveCeutical Medical Inc. (the Issuer) for the interim period ended Jun...